ZURICH (Reuters) – Roche announced on Friday the U.S. Food and Drug Administration has granted priority review to the Swiss pharmaceutical company’s bispecific antibody Glofitamab. Glofitamab is intended for patients …
Topic:
antibody
-
-
(Reuters) – Vir Biotechnology Inc said on Tuesday it had received $55 million in funding from the U.S. government to support its influenza-focused antibody drug that is expected to enter …
-
GENEVA (Reuters) – The World Health Organization (WHO) on Friday recommended two monoclonal antibody treatments against Ebola, saying the use of such drugs combined with better care had “revolutionised” the …
-
By Nancy Lapid (Reuters) – The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has …
-
-The U.S. Food and Drug Administration on Friday authorized Eli Lilly and Co’s COVID-19 antibody drug for people aged 12 and older at risk of severe illness, adding a tool …
-
DeSantis says Monoclonal antibody treatments just sitting on shelves as COVID-19 patients suffer after Biden administration ban
by Jeff JonesFlorida Governor Ron DeSantis is frustrated after the FDA has banned the use of Monoclonal antibodies for treatment of COVID-19 patients after the treatment has shown to be effective in …
-
Governor Ron DeSantis Highlights Monoclonal Antibody Treatment Success in Florida
-
Governor Greg Abbott today announced that the Texas Division of Emergency Management (TDEM), in partnership with local officials, launched a new COVID-19 therapeutic infusion center in College Station. The infusion …